Patent ID: 8377963
Filing Date: 2013-02-19
Classification: A61P,C07D

Abstract:
1. A method for treating a disease or condition by the inhibition of IRAP activity is implicated, the method comprising administering to a subject in need thereof an effective amount of a compound of Formula (I): wherein A is aryl, heteroaryl carbocyclyl or heterocyclyl, each of which may be optionally substituted, when R X is O, NR′ or S, wherein R′ is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted acyl, optionally substituted heteroaryl, optionally substituted carbocyclyl or optionally substituted heterocyclyl; R R R Y is hydrogen or C or a pharmaceutically acceptable salt or solvate thereof.